Caresyntax has closed a $100 million series C funding round that the Boston-based startup said will help further develop its digital surgery data platform and support expansion within its focus markets.
PFM Health Sciences headlined the raise, which included support from new backers Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital Partners, Arno Capital and Rezayat Invest. Prior investors IPF Partners, Relyens and Surgical.AI also participated.
This raise brings the tech company’s lifetime funding to $177.5 million.
Caresyntax’s enterprise products collect surgical data from inside of the operating room and through other sources such as medical devices, imaging or an organization’s electronic health record system.
By unifying these data streams, the company says it delivers a range of evidence-based insights that can drive decision-making inside of the operating room. Its artificial intelligence and automation tools are designed to help surgeons manage their workflows, hospital administrators monitor performance trends and